This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Mediclinic International 미래 성장

Future 기준 확인 1/6

현재 Mediclinic International 의 성장과 수익을 예측할 만큼 분석가의 범위가 충분하지 않습니다.

주요 정보

10.7%

수익 성장률

12.2%

EPS 성장률

Healthcare 수익 성장	27.7%
매출 성장률	3.6%
향후 자기자본 수익률	n/a
애널리스트 커버리지	Good
마지막 업데이트	30 May 2023

최근 미래 성장 업데이트

Recent updates

수익 및 매출 성장 예측

DB:MO4 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (GBP Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
3/31/2026	3,888	271	N/A	N/A	1
3/31/2025	3,684	255	330	551	6
3/31/2024	3,564	237	309	525	6
3/31/2023	3,441	212	183	422	6
9/30/2022	3,383	169	283	470	N/A
6/30/2022	3,308	160	329	512	N/A
3/31/2022	3,233	151	375	554	N/A
12/31/2021	3,199	135	321	483	N/A
9/30/2021	3,165	118	266	412	N/A
6/30/2021	3,080	93	183	324	N/A
3/31/2021	2,995	68	99	235	N/A
12/31/2020	2,987	-173	N/A	N/A	N/A
9/30/2020	2,979	-414	133	306	N/A
6/30/2020	3,031	-367	203	381	N/A
3/31/2020	3,083	-320	273	456	N/A
12/31/2019	3,070	-97	N/A	N/A	N/A
9/30/2019	3,057	126	246	443	N/A
6/30/2019	2,995	-12	175	394	N/A
3/31/2019	2,932	-151	104	344	N/A
12/31/2018	2,897	-380	N/A	N/A	N/A
9/30/2018	2,861	-610	23	277	N/A
6/30/2018	2,869	-551	57	311	N/A
3/31/2018	2,876	-492	91	345	N/A
12/31/2017	2,874	-211	N/A	N/A	N/A
9/30/2017	2,871	69	97	350	N/A
6/30/2017	2,810	149	121	364	N/A
3/31/2017	2,749	229	145	377	N/A
12/31/2016	2,565	210	155	375	N/A
9/30/2016	2,380	191	165	373	N/A
6/30/2016	2,244	184	N/A	347	N/A
3/31/2016	2,107	177	N/A	320	N/A
12/31/2015	2,080	211	N/A	314	N/A
9/30/2015	2,183	257	N/A	330	N/A
6/30/2015	2,042	245	N/A	327	N/A
3/31/2015	1,977	241	N/A	337	N/A
12/31/2014	1,901	221	N/A	312	N/A
9/30/2014	1,810	199	N/A	284	N/A
6/30/2014	1,751	193	N/A	270	N/A
3/31/2014	1,738	193	N/A	263	N/A
12/31/2013	1,652	82	N/A	253	N/A
9/30/2013	1,653	-33	N/A	257	N/A
6/30/2013	1,701	-55	N/A	256	N/A
3/31/2013	1,742	-79	N/A	253	N/A
12/31/2012	1,729	19	N/A	232	N/A
9/30/2012	1,730	118	N/A	213	N/A
6/30/2012	1,759	109	N/A	198	N/A

애널리스트 미래 성장 예측

수입 대 저축률: MO4 의 연간 예상 수익 증가율( 10.7% )이 saving rate( 0.2% 보다 높습니다. ).

수익 vs 시장: MO4 의 연간 수익( 10.7% ) German 시장( 21.1% 보다 느리게 성장할 것으로 예상됩니다. 21.1% 연간).

고성장 수익: MO4 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: MO4 의 수익(연간 3.6% ) German 시장( 5.6% 보다 느리게 성장할 것으로 예상됩니다. 5.6% 연간).

고성장 수익: MO4 의 수익(연간 3.6% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: MO4 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.

This company is no longer active

Mediclinic International 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Mediclinic International plc Provides Revenue Guidance for Fiscal 2022

Recent updates

Financial Conduct Authority Cancels the Listing of Mediclinic Shares on the London Stock Exchange and Delisting of Shares from the JSE and the NSX Expects to Take Effect on 7 June 2023

Mediclinic International's Cancellation of Shares from Official List and Main Market of LSE Expected to Take on 30 May 2023; Delisting of Shares from JSE and NSX Expected to Take Effect from Commencement of Trade on 7 June 2023

Mediclinic International plc(LSE:MDC) dropped from FTSE 350 (Ex Investment Companies) Index (GBP)

Cancellation of Listing of Mediclinic Shares on the LSE Is Expected on 26 May 2023

Mediclinic International plc (LSE:MDC) acquired Artisan Biomed.

Mediclinic International plc Approves Final Cash Dividend, Payable on 26 August 2022

Mediclinic International plc to Delist

Mediclinic International plc Approves Final Cash Dividend

Upcoming dividend of UK£0.03 per share

Remgro Wants Equal Partner in Possible Mediclinic Buyout

Mediclinic International Ordinary Shares to Be Deleted from OTC Equity

Independent Non-Executive Director recently bought €86k worth of stock

Full year 2022 earnings released: EPS: UK£0.20 (vs UK£0.092 in FY 2021)

Mediclinic International plc to Report First Half, 2023 Results on Nov 16, 2022

High number of new directors

Mediclinic International plc to Report Fiscal Year 2022 Results on May 25, 2022

High number of new directors

High number of new directors

First half 2022 earnings released: EPS UK£0.088 (vs UK£0.02 in 1H 2021)

High number of new directors

High number of new directors

Senior Independent Director J. Grieve has left the company

Independent Non-Executive Director Trevor Petersen has left the company

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.43 loss in FY 2020)

Mediclinic International plc Provides Revenue Guidance for Fiscal 2022

New 90-day high: €3.58

Non-Executive Director recently sold €59k worth of stock

First half 2021 earnings released: EPS UK£0.02

Revenue beats expectations

New 90-day high: €3.42

New 90-day high: €3.37

수익 및 매출 성장 예측

애널리스트 미래 성장 예측

주당 순이익 성장 예측

미래 자기자본 수익률

성장 기업 발견